RaQualia Pharma Inc. (4579.T) JPX

1,141.00

-119(-9.44%)

Updated at December 05 01:04PM

Currency In JPY

Valuation

Market Cap8.31B
Enterprise Value8.62B
P/E Ratio-50.21
PEG Ratio2.52
Price/Sales Ratio8.72
Price/Book Ratio4.2
Enterprise/Revenue8.65
Enterprise/EBITDA121.62

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.16
Operating Margin-0.08

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.09

Income Statement

Revenue3.11B
Revenue/Share141.02
Gross Profit2.48B
EBITDA188.27M
Net Income-495.03M
Diluted EPS-22.87

Balance Sheet

Total Cash3.62B
Total Cash/Share158.03
Total Debt3.2B
Total Debt/Equity0.51
Current Ratio4.8
Book Value Per Share274.26

Price History

52-Week Change163.62
52-Week High1,405
52-Week Low301
Moving Average 50 Days612.18
Moving Average 200 Days522.87

Statistics

Average Volume722,306
Shares Outstanding24.46M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A